PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25223338-0	2014	Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients.	Docetaxel	64-73	thymidylate synthetase	Homo sapiens	37-41	
33024525-0	2020	Relationship between the Expression of the Thymidylate Synthase and the Prognosis of Gastric Cancer Patients Treated with Combinational Chemotherapy Regimen Including Fluorouracil, Docetaxel and Cisplatin.	Docetaxel	181-190	thymidylate synthetase	Homo sapiens	43-63	
25888862-0	2015	Retraction note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients.	Docetaxel	81-90	thymidylate synthetase	Homo sapiens	54-58	
28901493-0	2017	High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.	Docetaxel	31-40	thymidylate synthetase	Homo sapiens	107-127	
28901493-9	2017	The level of TS protein was significantly decreased in wild-type TP53-containing cells with DOC treatment; TS expression levels were not affected in mutant-TP53 and TP53-null cells under the same conditions.	Docetaxel	92-95	thymidylate synthetase	Homo sapiens	13-15	
16926630-6	2006	The combination between erlotinib and docetaxel resulted in an approximately 50% reduction in thymidylate synthase activity (the molecular target of 5-fluorodeoxyuridine monophosphate, the active capecitabine anabolite) with an higher impact observed with DU145 cells than with PC3 cells.	Docetaxel	38-47	thymidylate synthetase	Homo sapiens	94-114	
22766915-6	2012	Downregulation of TS and DPD expression and upregulation of OPRT expression were induced by DOC treatment, suggesting that DOC enhanced the efficacy of 5-FU by altering the expression of its metabolic enzymes.	Docetaxel	92-95	thymidylate synthetase	Homo sapiens	18-20	
22766915-6	2012	Downregulation of TS and DPD expression and upregulation of OPRT expression were induced by DOC treatment, suggesting that DOC enhanced the efficacy of 5-FU by altering the expression of its metabolic enzymes.	Docetaxel	123-126	thymidylate synthetase	Homo sapiens	18-20